Business
5 top ASX cannabis shares in 2020
Investors in ASX cannabis shares have had a bumpy ride in 2020. Share prices were impacted by global oversupply issues in late 2019 then plunged in the March 2020 market downturn.
But the Australian medical marijuana industry is building momentum, continuing its growth trajectory in 2020 despite the impacts of COVID-19. According to Freshleaf analytics, the market tripled in size over 2020 with 30,000 active patients and $95 million in annual revenue.
As the industry matures, competition is increasing. The number of available products has doubled in the last year to 150, putting pressure on prices. Prices have trended downward, and are now on par with more mature markets such as Canada. With price decreases, patient doses have…
-
General22 hours agoToni Lamond, known for her roles in Annie Get Your Gun and My Fair Lady, dies aged 93
-
General23 hours agoPolice continue search for missing man Chris Thorne in Melbourne’s west
-
General23 hours agoPauline Hanson proves we have a two-tier senate
-
General12 hours agoSex work influencers call out lack of transparency as young girls targeted by viral social media content